Fesoterodine a new effective and well-tolerated antimuscarinic for the treatment of urgency-frequency syndrome: results of a phase 2 controlled study.
Chapple C1 1. Royal Hallamshire Hospital
| Abstract 142 |
| Clinical Pharmacology and Overactivity - Blue Room:Chaired by Harold Drutz and Alan Wein Scientific Podium Poster Session 16 |
| Friday 27th August 2004 |
| 14:23 - 14:30 |
|